Search Results - Habel, L.A

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    P1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50

    P1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50 by Suga, J., Thomas, S., Achacoso, N., Jiang, C., Chung, E., Solorzano-Pinto, A., Tse, P., Bulen, B.J., Khazanov, N.A., Lamb, L.E., Hovelson, D.H., Kwiatkowski, K., Johnson, D.B., Rhodes, D.R., Tomlins, S.A., Habel, L.A.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    3007 Herpes zoster in solid tumor and hematologic malignancy patients – a cohort study in a managed care organization

    3007 Herpes zoster in solid tumor and hematologic malignancy patients – a cohort study in a managed care organization by Habel, L.A, Ray, G.T, Horberg, M, Yawn, B, Li, Y, Castillo, A, Silverberg, M.J, Quesenberry, C.P, Saddier, P, Tran, T.N

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Occupation and Breast Cancer Risk in Middle-Aged Women

    Occupation and Breast Cancer Risk in Middle-Aged Women by Habel, Laurel A., Stanford, Janet L., Vaughan, Thomas L., Rossing, Mary Anne, Voigt, Lynda F., Weiss, Noel S., Daling, Janet R.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: